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The Renin-Angiotensin-Aldosterone System During Haemodialysis With
Acetate or Bicarbonate at Different Dialysate Sodium Concentrations
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Abstract. The hormones of the renin-angiotensin-
aldosterone system were measured during regular haemo-
dialysis with acetate or bicarbonate at dialysate sodium
concentrations of 135. 140, 145, and 150 mmol/1. Plasma
renin activity and aldosterone concentration were higher
during acetate haemodialysis than during bicarbonate
haemodialysis. At lower dialysate sodium concentrations,
plasma renin activity (acetate dialysis and bicarbonate
dialysis) and aldosterone concentration (only acetate
dialysis) were higher than they were at higher dialysate
sodium concentrations. Plasma renin activity increased
during acetate dialysis, but did not change during
bicarbonate dialysis. Aldosterone and potassium con-
centrations were positively correlated. Aldosterone
decreased during haemodialysis (increase to predialysis
values at the end of haemodialysis (4 h) at lower dialysate
sodium concentrations). It is concluded that the renin-
angiotensin-aldosterone system is activated more during
acetate dialysis than during bicarbonate dialysis.
Aldosterone concentrations seem to be related more
closely to serum potassium than to renin-angiotensin-
aldosterone system and to serum sodium intradialytically.
Key words: Acetate; Bicarbonate; Haemodialysis; High-
low sodium dialysis; Renin-angiotensin-aldosterone
system.
Introduction
Dialytic intolerance to fluid removal is often a problem in
patients during haemodialysis. Either fluid and sodium
overload [1-3] or the renin-angiotensin-aldosterone
system ('inappropriately high plasma renin activity') are
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D 7400. Tubingen, FRG.
important in haemodynamic stability and blood pressure
regulation in patients with end-stage renal disease.
The present study examines the renin-angiotensin-
aldosterone system at conditions of water deprivation
during regular haemodialysis with different buffers and
different dialysate sodium concentrations.
Patients and Methods
Six patients with end-stage renal disease were examined.
Clinical data was as follows: chronic haemodialysis for
0.5-7.0 years; aged 17-66 years; three male and three
female. Aetiology of the renal failure was three polycystic
kidneys, two chronic pyelonephritis, and one hydro-
nephrosis. Daily urine output was < 100 ml in four
patients and < 600 ml in the other two; no patient received
antihypertensive treatment, none was bilaterally
nephrectomised.
The subjects were examined during acetate dialysis at
four different dialysate sodium concentrations: 135, 140,
145 and 150 mmol/1. In each case haemodialysis with the
same dialysate sodium concentration had been performed
2 days before the haemodialysis entered in this study.
Mean volume removal was 2.10 litres during bicarbonate
dialysis and 2.15 litres during acetate dialysis. Five of the
six patients were examined during bicarbonate dialysis at
the same four sodium concentrations.
Blood samples were obtained from the arterial line
before dialysis, after 1 h 20 min, after 2 h 40 min, and after
4h of dialysis (end of haemodialysis). Plasma renin
activity, aldosterone concentration , angiotensin II con-
centration and serum sodium and potassium concen-
trations were measured. Blood pressure was measured
every 20 min by means of a cuff sphygmomanometer.
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Table I. Plasma renin activity, angiostensin II and aldostcrone: Mean value of measurements during haemo-
dialysis and range of values
Plasma renin activitv (ng ml per h)
x±SEM
range
Angiostensin II (pg ml)
x + SEM
Aldosterone (pg.ml)
x±SEM
range
Acetate dialysis
2.13 + 0.30
0.07-9.20
90.7+10.9
515±67
41-2400
Bicarbonate dialysis
0.95 ±0.13
0.07-4.81
28.9+1.7
446 ±62
34-2400
P
< 0.0001
< 0.0001
<0.05
Range of normal values: plasma renin activity (supine position). 0.12-1.59 ng/ml per h; angiostensin II,
5 15 pg, ml: aldosterone (supine position). 10-160 pg/ml
Table 2. Diastolic blood pressure, plasma renin activity and aldosterone concentration. Mean values of
measurements during dialysis at each sodium concentration in dialysate (cNaD/mmol per 1)
Plasma renin activity (ng ml per h)
cNaD=135
140
145
150
Aldosterone (pg/ml)
cNaD=l35
140
145
150
Diastolic blood pressure (mmHg)
cNaD=135
140
145
150
Acetate dialysis (n = 6)
2.98 ±0.70 1
2.78 + 0.63 i
2.12 + 0.50; • .
l.55±0.39 1 *
Acetate dialysis (n = 6)
760±142
653 ±136
1
 |
* •*
515±1I2 I I
364±72
Acetate dialysis (n = 6)
7I.5±1.2
75.5 + 2.1
1 ^
• •
•
77.5+1.7 I T
8O.3±I.7 * '
Bicarbonate dialysis (n = 5)
1.39 + 0.37 1 | I
0.94 + 0.24 1 i !
0.77 ±0.20 f *
0.72 ±0.20 1
Bicarbonate dialysis (n = 5)
546±129
416+120
390+125
430 ±127
Bicarbonate dialysis (n = 5)
68.5+1.5 1 1 i
77.0 ±2.2 | ; •
74.o ±2.1 : T
73.4+1.3 * '
*/><0.05: *'P<0.0l: ***/»<0.001.
Haemodialysis was performed with the dialyser C-
DAK Artificial Kidney I35sce (CD Medical GmbH,
Munich. FRG); 1.4 m2 surface, saponified cellulose ester,
with a dialysate flow of 444ml/min, and a blood flow of
250 ml/min (Cobe Centry 2000 Rx; Cobe Laboratories
GmbH, Kirchheim/Munchen, FRG)
We used dialysate preparations for bicarbonate dialysis
(Fa. Fresenius AG, Bad Homburg, FRG; PGS 22 + 8.4%
NaHCOj) and for acetate dialysis (Fa. B. Braun,
Melsungen, FRG; Y 108). Final dialysate concentrations
were: potassium 2.0-2.2 mmol/1; sodium 135, 140,
145, 150 mmol/1; acetate 35-39 mmol/1; bicarbonate
31-35 mmol/1 (+ 3 mmol/1 acetate).
Commercially available kits were used to measure
plasma renin activity (Fa. Serono Diagnostika GmbH,
Freiburg, FRG; Renin MAIA), and angiostensin II and
aldosterone (Fa. H. Biermann Medizinische Systeme
GmbH, Bad Nauheim, FRG; J—125 Angiotensin II and
Coat-A-Count Aldosteron).
Sodium and potassium concentrations were measured
with ion-selective electrodes (Nova 1, Nova Biomedical
GmbH, Darmstadt, FRG). Dialysate sodium and
potassium concentrations were controlled by direct
measurements.
Statistical evaluation was performed by means of
Student's paired t test, and the coefficient of correlation.
P values less than 0.05 were considered statistically signifi-
cant. Data are expressed as mean + SEM. To improve
legibility, in Figs 1-3, SEM are not drawn in at all
dialysate sodium concentrations.
Results
Plasma renin activity, angiostensin II and aldosterone
concentration were higher during acetate dialysis than
during bicarbonate dialysis (Table 1).
Mean values of plasma renin activity, aldosterone con-
centration and diastolic blood pressure during acetate
dialysis and bicarbonate dialysis at different dialysate
sodium concentrations are shown in Table 2.
Because of rather large individual differences in plasma
renin activity and aldosterone concentration, we exam-
ined plasma renin activity and aldosterone in relation to
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individual plasma renin activity and aldosterone values
predialysis at 135 mmol/1 dialysate sodium concentration.
During acetate dialysis relative plasma renin activity
increased (P < 0.01), but during bicarbonate dialysis there
was no significant change of relative plasma renin activity
(Fig. 1). Relative aldosterone concentration decreased
during acetate dialysis at 145 and 150 mmol/1 dialysate
sodium concentration in comparison to predialysis values
(P<0.01). At 135 and 140 mmol/1 during acetate dialysis
a decrease (P<0.05 or 0.01) in relative aldosterone con-
centration was demonstrated at 1 h 20 min and at 2 h
40 min, but not at 4 h, the end of haemodialysis (Fig. 2).
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(/)<0.05 or 0.01). During bicarbonate dialysis at
135 mmol/1 dialysate sodium concentration, relative
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Fig. 3. Relative aldosterone concentration during haemodialysis with
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Fig. 2. Relative aldosterone concentration during haemodialysis with
acetate.
During bicarbonate dialysis relative aldosterone con-
centration decreased at 140, 145 and 150 mmol/1 dialysate
sodium concentration in comparison to predialysis values
Serum sodium concentration correlated negatively
with relative plasma renin activity values (r= — 0.45
in acetate dialysis, r=— 0.66 in bicarbonate dialysis;
P<0.01 each). Volume loss correlated positively with
the plasma renin activity relative to the predialysis values
at each dialysate sodium concentration during acetate
dialysis (r = 0.44; P<0.0l), but not during bicarbonate
dialysis.
Serum sodium concentration correlated negatively
with relative aldosterone concentration (r=— 0.38
(acetate dialysis), r=— 0.40 (bicarbonate dialysis);
P<0.01 each).
Serum potassium concentration decreased during
haemodialysis (/»<0.01) and correlated positively with
aldosterone and relative aldosterone concentration
(r=0.45 (acetate dialysis), r=0.55 (bicarbonate dialysis);
P<Q.Ql each) (Fig. 4). Plasma renin activity correlated
positively with aldosterone concentration (r=0.72
(acetate dialysis), r = 0.70 (bicarbonate dialysis), P<0.01
each).
Diastolic blood pressure showed a slight but not signifi-
cant tendency to decrease during acetate dialysis and
bicarbonate dialysis. During acetate dialysis low diastolic
blood pressure is demonstrated at low dialysate
sodium concentrations (RR, 35 **< R R , 4 O n s < RR14J
*<RR150; *P<0.05, **: P<0.0\). During bicarbonate
dialysis, diastolic blood pressure at 135 mmol/1 dialysate
sodium concentration was significantly less than at higher
dialysate sodium concentrations, but no further increase
in blood pressure with increasing dialysate sodium
concentration was demonstrated.
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Fig. 4. Relative aldosterone concentration (predialytic value = 100%)
and serum potassium concentration during haemodialysis with acetate
and bicarbonate.
Heart rate was significantly higher during acetate
dialysis than during bicarbonate dialysis (/>< 0.001); it
increased, but not significantly, during acetate dialysis
(approximately 10 per min), and was unchanged during
bicarbonate dialysis.
Serum sodium concentration increased during bicar-
bonate dialysis at 150mmol/l dialysate sodium concen-
tration (/><0.05), and decreased during acetate dialysis
at 135 mmol/1 dialysate sodium concentration (P<0.05);
at other dialysate sodium concentrations no sig-
nificant changes in serum sodium concentration were
demonstrated.
Discussion
Several studies show an elevated plasma renin activity in
patients with end-stage renal disease [4-7], although
others do not confirm these results [8-9] Van Stone et al
[10] examined six patients during haemodialysis with
a dialysate sodium concentration of 131, 142 and
150 mmol/1, and did not find significant differences
between the plasma renin activity at the different sodium
concentrations. Regarding patients with kidneys remain-
ing in situ, plasma renin activity was shown to be higher
postdialysis than predialysis [5-9,11,12]. Van Stone et al
[10,13] confirmed these results in six patients (including
one nephrectomised) for all examined dialysate sodium
concentrations. Tuma et al [ 14] and Juncos et al [9] demon-
strated a fall in plasma renin activity in nephrectomised
patients during haemodialysis.
In some of the above-mentioned studies haemodialysis
was performed using acetate as buffer [7,10,11,13,14], but
the buffer employed was not stated in the other studies
[4-6,8,9,12]. Thus, our results confirm these reports
regarding the increase of plasma renin activity during
acetate dialysis in non-nephrectomised patients. Rapid
changes in fluid and sodium/potassium content are able to
cause high renin release. Juncos et al [9] suggested an
increase in plasma renin activity caused by ultrafiltration.
The inverse correlation of relative plasma renin activity
with serum sodium concentration demonstrated that a
low sodium concentration is followed by high plasma
renin activity, suggesting that a decrease in sodium con-
centration (accompanied by decrease of blood volume)
stimulates renin release. However, in that study, a decrease
in serum sodium concentration was only examined during
haemodialysis with low sodium concentrations in the
dialysate.
The present results show that serum sodium concen-
tration is not the main factor stimulating renin release
during acetate dialysis, because the increase of plasma
renin activity during acetate dialysis at a dialysate sodium
concentration of 145 and 150 mmol/1 occurred in spite of
constant serum sodium concentrations. Changes in blood
volume are therefore supposed to be more important for
renin release.
The role of plasma renin activity is different during
acetate dialysis compared to bicarbonate dialysis, there is
an increase of plasma renin activity during acetate dialysis
but no change during bicarbonate dialysis. This might
be due to several side-effects of acetate when used as a
dialysate buffer:
(a) Acetate has a known vasodilating effect [26-31].
(b) During bicarbonate dialysis blood volume is preserved
better than during acetate dialysis, plasma refilling rate is
higher, and plasma refilling was said to take place earlier
during the haemodialysis procedure [15].
(c) In addition, acetate possibly has a depressant effect on
myocardial function [26, 27, 29, 32, 33], but not all
authors support this view [31, 34-36].
Secondary to those mechanisms the renin-angiotensin-
aldosterone system is stimulated more during acetate
dialysis than during bicarbonate dialysis, with higher
values of plasma renin activity, aldosterone concen-
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tration, angiotensin II and different dialysate sodium con-
centrations influencing those levels more when acetate is
used as a buffer.
No information concerning the behaviour of the renin-
angiotensin-aldosterone system during bicarbonate
dialysis, especially in contrast to acetate dialysis, is
available in the literature.
Most authors have found elevated aldosterone concen-
trations in patients with end-stage renal disease [6, 8, 11,
16]. Bonomini et al [4] found an increase in aldosterone
concentration with loss of kidney function, but aldoster-
one concentration remained in the normal range (no
patients with end-stage renal disease on chronic haemo-
dialysis were examined). A decrease of aldosterone con-
centration during haemodialysis was demonstrated by
several authors [6, 8, 17, 18. 20].
At different dialysate sodium concentrations. Van
Stone et al [10] found a decrease of aldosterone concen-
tration during haemodialysis without weight loss; also at
. a dialysate sodium concentration of 152mmol/l with a
2-kg weight loss. During haemodialysis at 131 and
142mmol/l sodium concentration and 2-kg weight loss,
however, an increase in aldosterone concentration was
reported.
Henrich et al [20] demonstrated a decrease in aldoster-
one concentration despite an increase in plasma renin
activity during regular haemodialysis, whereas when
potassium concentration was kept constant, an increase
of plasma renin activity as well as of aldosterone concen-
tration was demonstrated. The authors concluded that
the loss of the stimulus of a high serum potassium concen-
tration, with potassium decreasing during haemodialysis,
would override the influence of fluid depletion and
increased plasma renin activity on aldosterone secretion.
Weidmann and Maxwell [23] reported similar results.
In the present study a decrease of aldosterone concen-
tration both during acetate dialysis and bicarbonate
dialysis was shown, confirming the results of Henrich
et al [20] and Weidmann and Maxwell [23].
Thus a decrease of aldosterone concentration, being an
index/measure of aldosterone release because of aldoster-
one's short half-life of 29.7 min in plasma [27], is thought
to be caused mainly by the decrease in serum potassium
concentration.
At lower sodium concentrations in the dialysate,
however, aldosterone concentration reached predialysis
concentrations again at the end of haemodialysis. At the
end of haemodialysis, high potassium concentrations, as a
stimulus to aldosterone release, no longer exist. Therefore
the release of aldosterone at the end of haemodialysis has
to be stimulated by other factors such as plasma renin
activity. Plasma renin activity has been shown to be
highest at low dialysate sodium concentrations and to
increase during acetate dialysis. Thus plasma renin
activity is thought to be one cause of the increase of
aldosterone concentration at the end of low-sodium
haemodialysis with weight loss, the increase of aldoster-
one concentration being more marked during acetate
dialysis than during bicarbonate dialysis.
. Another possible reason for the intradialytic decrease
of aldosterone concentration could be the loss of
aldosterone across the dialyser. Aldosterone is a mid-
sized molecule with a molecular weight of about 380 U,
and is dialysable. However, according to Iitake et al [25]
the fall in postdialysis aldosterone concentration cannot
be explained by the loss of plasma aldosterone into the
dialysate.
High levels of plasma renin activity and angiostensin II
during acetate dialysis contribute to stabilisation of blood
pressure. Blood pressure is not lower during acetate dialy-
sis compared to bicarbonate dialysis in spite of the vaso-
dilatory effect of acetate and the slower plasma refilling.
However, diastolic blood pressure is thought to depend
more on dialysate sodium concentration during acetate
dialysis than during bicarbonate dialysis.
In conclusion, the renin-angiotensin-aldosterone sys-
tem is activated more during acetate dialysis than during
bicarbonate dialysis, and more at lower dialysate sodium
concentrations than at higher concentrations. Higher
activation of the renin-angiotensin-aldosterone system
during acetate dialysis is thought to be secondary to the
vasodilatory effect of acetate and the slower refilling of
plasma volume. Either the renin-angiotensin-aldosterone
system or serum potassium concentration stimulate aldo-
sterone release, and these effects are modulated by other
mechanisms such as sensitisation of the zona glomerulosa
by sodium depletion [21,22].
Aldosterone concentration seems to be related more
closely to serum potassium concentrations than to the
renin-angiotensin-aldosterone system and serum sodium
concentrations intradialytically.
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